Sökresultat - "disproportionality analysis"

Investigating the Benefit-Risk Profile of Drugs: From Spontaneous Reporting Systems to Real-World Data for Pharmacovigilance

Imbrici, Paola^Aff3, De Bellis, Michela^Aff3, Liantonio, Antonella^Aff3, De Luca, Annamaria^Aff3

Nicolotti, Orazio^Aff2, Walker, John M.^Aff1

Real-world safety of maribavir: a retrospective study based on signal detection in the FDA adverse event reporting system

Gong, Qineng^Aff2, Zhang, Linlin^Aff1, Wu, Hui, Miao, Yang, Huang, Lei, Yin, Cunlin, Hu, Ye^{Aff1, IDs11096025018694_cor1}

Signal detection of ferric carboxymaltose-induced serious adverse events: disproportionality analysis of FAERS and VigiBase data and systematic review of case reports

Galigutta, Reddikumar Reddy^Aff1, Thomas, Christy^Aff1, Rathod, Mahesh^Aff1, Hasik, P. N., Ray, R. S., Prakash, Jai, Undela, Krishna^{Aff1, IDs0022802503849z_cor1}

Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System

Barbieri, Maria Antonietta, Russo, Giulia, Cicala, Giuseppe, Andò, Giuseppe, Franchina, Tindara, Silvestris, Nicola, Santarpia, Mariacarmela, Spina, Edoardo^{Aff1, IDs00228025038248_cor1}

Post-marketing safety of pralsetinib: a real-world disproportionality analysis based on the FDA adverse event reporting system database

Shi, Zheng^{Aff1, Aff2, Aff4}, Shao, Keda^{Aff1, Aff2, Aff4}, Wang, Ke^{Aff1, Aff3, Aff4}, Xu, Manyi^{Aff1, Aff3, Aff4}, Yu, Xiayao^{Aff1, Aff2, Aff4}, Xu, Chunwei, Li, Qin^{Aff1, Aff4}, Song, Zhengbo^{Aff1, Aff2, Aff4, IDs1109602501917z_cor1}

Pancreatitis associated with BRAF inhibitors: a disproportionality analysis based on the Food and Drug Administration Adverse Event Reporting System

Wang, Shoujun, Wang, Jinjing, Zhang, Huahua, Wang, Jiangfeng^{Aff3, IDs11096025019142_cor1}

Safety of Janus kinase inhibitors in rheumatoid arthritis: a disproportionality analysis using FAERS database from 2012 to 2022

Mikaeili, Bahar^{Aff1, IDs10067025073609_cor1}, Alqahtani, Zuhair A.^{Aff1, Aff2}, Hincapie, Ana L., Guo, Jeff Jianfei

An Age-Adjusted Disproportionality Measure for Pediatric Pharmacovigilance

Belloni, Pietro^Aff3, Pizzolato, Federica^Aff4

Pollice, Alessio, editor^Aff1, Mariani, Paolo, editor^Aff2

Dose-dependent pancreatitis risk associated with GLP-1 agonists

Gu, Joyce Hanyue^{Aff1, IDs4020002401552x_cor1}, Samarneh, Mark

Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System

He Chen, Sixing Liu, Shuai Gao, Hangyu Shi, Yan Yan, Yixing Xu, Jiufei Fang, Weiming Wang, Huan Chen, Zhishun Liu

electronic resource

Visa

Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance

Monia Donati, Angela Boccia, Fabrizio De Ponti, Elisabetta Poluzzi, Emanuel Raschi

electronic resource

Visa

Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis

Li, Wanshu, Yu, Yanan, Li, Minghui, Fang, Qing, jin, Xin, Lin, Hangjuan, Xu, Jun^{Aff2, IDs1109602401778y_cor7}

Integration of FAERS, DrugBank and SIDER Data for Machine Learning-based Detection of Adverse Drug Reactions

Schreier, Tobias^{Aff1, IDs13222024004861_cor1}, Tropmann-Frick, Marina, Böhm, Ruwen^{Aff2, Aff3}

Adverse events reporting of edaravone: a real-world analysis from FAERS database

Qi Shang, Jie Zhou, Junchang Ye, Maohua Chen

electronic resource

Visa

A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database

Jie Li, Jun Xie, Yi Han, Wei Zhang, Yilei Wang, Zhitao Jiang

electronic resource

Visa; Visa

Conducting a real-world study of Tumor Necrosis factor-alpha inhibitors-induced Systemic Lupus Erythematosus based on the FAERS database

Mengjiao He, Jiale Yang, Simin Yan, Qing Shu, Peng Cheng Liu

electronic resource

Visa

Disproportionality analysis of Raynaud’s phenomenon associated with calcitonin gene-related peptide inhibitors using the Food and Drug Administration adverse event reporting system

Nai Lee, Ji Hoon Ok, Su-jin Rhee, Yun Kim

electronic resource

Visa

Real-world pharmacovigilance study of drug-induced autoimmune hepatitis from the FAERS database

Bu-kun Zhu, Si-ying Chen, Xiang Li, Shu-yun Huang, Zhan-yang Luo, Wei Zhang

electronic resource

Visa

A disproportionality analysis of FDA adverse event reporting system events for misoprostol

Li Yang, Wenting Xu

electronic resource

Visa

A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases

Siyu Lou, Zhiwei Cui, Yingyong Ou, Junyou Chen, Linmei Zhou, Ruizhen Zhao, Chengyu Zhu, Li Wang, Zhu Wu, Fan Zou

electronic resource

Visa